Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all- trans -retinoic acid metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Retinoids, particularly all- trans -retinoic acid (RA), are potent regulators of cell differentiation, cell proliferation, and apoptosis. The role of all- trans -RA during development and in the maintenance of adult tissues has been well established. The control of all- trans -RA levels in cells and tissues is regulated by the balance between its biosynthesis and its catabolism to inactive metabolites. The cytochrome P450 enzyme P450RAI (herein renamed P450RAI-1) is partially responsible for this inactivation of all- trans -RA. In this report, we describe the identification, molecular cloning, and characterization of a second related enzyme, P450RAI-2, which is also involved in the specific inactivation of all- trans -RA. Transiently transfected P450RAI-2 can convert all- trans -RA to more polar metabolites including 4-oxo-, 4-OH-, and 18-OH-all- trans -RA. Competition experiments with other retinoids suggest that all- trans -RA is the preferred substrate. The high level of expression of P450RAI-2, particularly in the cerebellum and pons of human adult brain, suggests a unique role for this enzyme in the protection of specific tissues from exposure to retinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, ATRA can regulate its levels in target organs through catabolic processes, especially through interaction with the enzymes CYP26A1, CYP26B1 and CYP26C1 [179,180,181,182].”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [180]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Current Understanding of the Molecular Actions of Vitamin D
JONES, G., STRUGNELL, S. A., & DeLUCA, H. F. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1193 · Cited by 1,274
Self-citationEmbryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Retinoids in cancer chemoprevention
Lotan, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801164 · Cited by 423
White, J. A., Beckett-Jones, B., Guo, Y.-D., Dilworth, F. J., Bonasoro, J., Jones, G., & Petkovich, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18538 · Cited by 402
Self-citationIdentification of the Retinoic Acid-inducible All-trans-retinoic Acid 4-Hydroxylase
White, J. A., Guo, Y.-D., Baetz, K., Beckett-Jones, B., Bonasoro, J., Hsu, K. E., Dilworth, F. J., Jones, G., & Petkovich, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29922 · Cited by 382
Self-citationRetinoic acid biosynthesis and metabolism
Napoli, J. L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801182 · Cited by 378
Fujii, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4163 · Cited by 353
Research works printed but not linked: 3
- L Gudas, M Sporn, A Roberts The Retinoids, eds M Sporn, A Roberts, D S Goodman (Raven, New York), pp. 443–520 (1994).
- E G Bligh, W J Dyer Can J Biochem 37, 911–917 (1957).
- Loudig O. Babichuk C. White J. Abu-Abed S. Mueller C. & Petkovich M. (2000) Mol. Endocrinol. in press.
Cited by
Items 101–200 of 289
Han, B., Xia, H., Sun, J., Yang, Y., & Peng, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22056 · Cited by 48
“As an RA-metabolizing enzyme, cyp26a1 creates an RA gradient for normal embryonic development (Hernandez et al., 2007; White et al., 2007), and the disruption of the cyp26a1 gene causes many developmental defects (Abu-Abed et al., 2001; Sakai et al., 2001).”
BackgroundWilli-Monnerat, S., Migliavacca, E., Surdez, D., Delorenzi, M., Luthi‐Carter, R., & Terskikh, A. V. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.01.009 · Cited by 48
Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair
Wang, S., Yu, J., Kane, M. A., & Moise, A. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107415 · Cited by 47
Özpolat, B., Mehta, K., & Lopez‐Berestein, G. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500174737 · Cited by 48
“Investigators also recently identified two more members of this new RA-metabolizing P450RAI family, CYP26B1 and CYP26C1, and showed that they convert ATRA to its less active, easily extractable metabolites [24,25].”
BackgroundFocal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1
Slavotinek, A. M., Mehrotra, P., Nazarenko, I. A., Tang, P. L.-F., Lao, R., Cameron, D. A., Li, B., Chu, C., Chou, C., Marqueling, A. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds477 · Cited by 47
“Total lipids were extracted using a modified Bligh-Dyer procedure (44) and 500 ml of the aqueous layer was taken to measure radioactivity.”
MethodSelf-citationVerfaille, C. J., Borgers, Μ., & Steensel, M. A. M. V. (2007) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06541.x · Cited by 46
Moise, A. R., Isken, A., Domínguez, M., de Lera, A. R., von Lintig, J., & Palczewski, K. (2007) · Biochemistry · doi:10.1021/bi062147u · Cited by 45
Breher-Esch, S., Sahini, N., Trincone, A., Wallstab, C., & Borlak, J. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0438-7 · Cited by 43
Fluconazole alters CYP26 gene expression in mouse embryos
Tiboni, G. M., Marotta, F., & Carletti, E. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.01.001 · Cited by 44
Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling
Zhang, W., Levi, L., Banerjee, P., Jain, M. K., & Noy, N. (2015) · Oncotarget · doi:10.18632/oncotarget.5767 · Cited by 44
“In accordance with activation of RAR and suppression of PPAR-mediated activity by KLF2, analyses of cultured cells (Figure S1F-S1I) and of tumors that arose in NCr mice showed that overexpression of KLF2 upregulated levels of mRNA of the endogenous the RAR target genes BTG2 [26] and CYP26a [46, 47] (Figure 2H).”
BackgroundPolymorphism in the Retinoic Acid Metabolizing Enzyme CYP26B1 and the Development of Crohn’s Disease
Fransén, K., Franzèn, P., Magnuson, A., Elmabsout, A. A., Nyhlin, N., Wickbom, A., Curman, B., Törkvist, L., D’Amato, M., Bohr, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072739 · Cited by 46
“Much of the atRA is likely degraded by CYP26A1, CYP26B1 and CYP26C1, where each CYP26 gene has specific expression patterns in the developing organism [3,9–11].”
BackgroundAlekseenko, Z., Dias, J. M. M., Adler, A. F., Kozhevnikova, M. N., van Lunteren, J. A., Nolbrant, S., Jeggari, A., Vasylovska, S., Yoshitake, T., Kehr, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30777-8 · Cited by 43
Romand, R., Kondo, T., Fraulob, V., Petkovich, M. P., Dollé, P., & Hashino, E. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20936 · Cited by 43
“In addition, mutant mouse embryos deficient for Raldh2 show developmental abnormalities similar to those observed in embryos deprived of retinoids (Niederreither et al., 1999; White et al., 2000).”
BackgroundSelf-citationRegulation of germ cell meiosis in the fetal ovary
Spiller, C. M., Bowles, J., & Koopman, P. A. (2012) · The International Journal of Developmental Biology · doi:10.1387/ijdb.120142pk · Cited by 43
Zolfaghari, R., Cifelli, C. J., Lieu, S. O., Chen, Q., Li, N., & Ross, A. C. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2006 · Cited by 42
“In mammals, three evolutionarily conserved genes, CYP26A1, CYP26B1, and CYP26C1, have been shown to display different yet partially overlapping expression patterns during embryonic development and in adult tissues (17, 33, 34, 43, 50, 51).”
BackgroundComparative genomics identifies genes mediating cardiotoxicity in the embryonic zebrafish heart
Chen, J., Carney, S. A., Peterson, R. E., & Heideman, W. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00214.2007 · Cited by 42
“Cluster 1 includes cyp26a1 and cyp26b1, encoding cytochrome P-450s that inactivate RA by converting it to 4-oxo-RA and 4-hydroxy-RA (35, 36).”
BackgroundLeukocyte Homing, Fate, and Function Are Controlled by Retinoic Acid
Guo, Y., Brown, C. C., Ortiz, C., & Noelle, R. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00032.2013 · Cited by 42
“Even though 1 M ATRA minimally induced Raldh2 expression in BMDC or splenic DC, it moderately enhanced GM-CSF and/or IL-4-induced Raldh2 expression on BMDCs.”
BackgroundInfluentialNaylor, R. W., Skvarca, L. B., Thisse, C., Thisse, B., Hukriede, N. A., & Davidson, A. J. (2016) · Nature Communications · doi:10.1038/ncomms12197 · Cited by 41
Armstrong, J. L., Taylor, G. A., Thomas, H. D., Boddy, A. V., Redfern, C. P. F., & Veal, G. J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603779 · Cited by 41
“Three mammalian RA-inducible P450s have been characterised, termed P450RAIs or CYP26s (White et al, 1997, 2000).”
BackgroundLoriè, E. P., Cools, M., Borgers, Μ., Wouters, L., Shroot, B., Hagforsen, E., Törmä, H., & Vahlquist, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08895.x · Cited by 42
Loriè, E. P., Chamcheu, J. C., Vahlquist, A., & Törmä, H. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0937-7 · Cited by 42
A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis
Krivospitskaya, O., Elmabsout, A. A., Sundman, E., Söderström, L. Å., Овчинникова, О. А., Gidlöf, A. C., Scherbak, N. N., Norata, G. D., Samnegård, A., Törmä, H., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00094 · Cited by 40
“CYP26A1 was the first member of the CYP26 family to be identified, characterized and cloned (22,23).”
BackgroundOcaya, P., Elmabsout, A. A., Olofsson, P. S., Törmä, H., Gidlöf, A. C., & Sirsjö, A. (2010) · Journal of Vascular Research · doi:10.1159/000317397 · Cited by 40
“In contrast, CYP26, a family of cytochrome P450 enzymes, have a higher specificity for atRA, and convert atRA into 4-hydroxyretinoic acid, 4-oxoretinoic acid and 18-hydroxyretinoic acid [ ,”
BackgroundRétinoïdes : mécanismes d’action
Berbis, P. (2010) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(10)70036-3 · Cited by 40
Constructing the mammalian neocortex: the role of intrinsic factors
Job, C., & Tan, S. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00070-8 · Cited by 40
Introductory remarks on human CYPs
Nelson, D. R. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001385 · Cited by 38
“Most of the 15 missing P450s (CYP2A7 (4), 2R1, 2S1 (5), 2U1, 2W1, 4A20 (or 4Z1), 4A22 (6), 4F11 (7), 4F22, 4V2, 4X1, 20, 26B1 (8,9), 26C1, 27C1) have been described only in the last year or two.”
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away
Nagai, Y., & Ambinder, A. J. (2023) · Cancers · doi:10.3390/cancers15143535 · Cited by 36
Shimshoni, J. A., Roberts, A. G., Scian, M., Topletz, A. R., Blankert, S. A., Halpert, J. R., Nelson, W. L., & Isoherranen, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404475 · Cited by 36
“CYP26A1 and CYP26B1 have also been identified as the key enzymes that regulate atRAmetabolism in other tissues during development and in adulthood (11, 12, 14, 15).”
BackgroundMurphy, K. A., Harsch, B. A., Healy, C. L., Joshi, S. S., Huang, S., Walker, R. E., Wagner, B. M., Ernste, K. M., Huang, W., Block, R., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab111 · Cited by 37
Gomaa, M. S., Bridgens, C. E., Aboraia, A. S., Veal, G. J., Redfern, C. P. F., Brancale, A., Armstrong, J. L., & Simons, C. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101583w · Cited by 35
Wen, J., Lopes, F., Soares, G., Farrell, S. A., Nelson, C., Qiao, Y., Martell, S., Badduke, C., Bessa, C., Ylstra, B., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-100 · Cited by 35
“In addition, in many human cell lines CYP26B1 mRNA is inducible by retinoic acid treatment while in rodents cyp26b1 expression correlates with dietary vitamin A intake [19-22].”
BackgroundVitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease
Barbalho, S. M., Goulart, R. D. Á., & Batista, G. L. D. S. A. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1543588 · Cited by 35
Snyder, J. M., Zhong, G. G., Hogarth, C. A., Huang, W., Topping, T., LaFrance, J., Palau, L., Czuba, L. C., Griswold, M. D., Ghiaur, G., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001734r · Cited by 34
“The Cyp26 family includes three enzymes, Cyp26a1, Cyp26b1, and Cyp26c1 of which Cyp26a1 and Cyp26b1 are necessary for embryonic development and survival during fetal life (White et al., 1994, 2000; Fujii et al., 1997; Taimi et al., 2004; Pennimpede et al., 2010).”
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
Wang, L., Peng, W., Wu, T., Deng, P., & Zhao, Y. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0086-x · Cited by 34
Alder, A., Bigler, P., Werck‐Reichhart, D., & Al‐Babili, S. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07224.x · Cited by 34
Vitamin A: Nutritional Aspects of Retinoids and Carotenoids
Ross, A., & Harrison, E. H. (2013) · CRC Press eBooks · doi:10.1201/b15413-2 · Cited by 32
Consiglio, E. D., Pistollato, F., Gyves, E. M., Bal‐Price, A., & Testai, E. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.09.010 · Cited by 31
Loriè, E. P., Gånemo, A., Borgers, Μ., Wouters, L., Blockhuys, S., Plassche, L., Törmä, H., & Vahlquist, A. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0573 · Cited by 31
A Novel Cytochrome P450, Zebrafish Cyp26D1, Is Involved in Metabolism of All-trans Retinoic Acid
Gu, X., Xu, F., Song, W., Wang, X., Hu, P., Yang, Y., Gao, X., & Zhao, Q. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0362 · Cited by 30
“However, there are reports that suggested that the metabolites of all-trans RA produced by other Cyp26 members also include 18-OH-RA in addition to 4-oxo-RA and 4-OH-RA (16, 18, 20, 30) or 5,8-epoxy-RA (17).”
BackgroundMadaro, A., Torrissen, O. J., Whatmore, P., Lall, S. P., Schmeisser, J., Verlhac-Trichet, V., & Olsen, R. E. (2020) · Marine Biotechnology · doi:10.1007/s10126-020-09980-5 · Cited by 30
“The cytochrome P450 enzymes CYP26A1, CYP26B1, and CYP26C1 carry out the catabolism of retinoic acid to 4-hydroxy-retinoic acid, 4-oxo-retinoic acid, and 18- hydroxy-retinoic acid (White et al. 2000; White et al. 2007).”
BackgroundLee, S., Perera, L., Coulter, S. J., Mohrenweiser, H. W., Jetten, A. M., & Goldstein, J. A. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32801152d6 · Cited by 30
“CYP26A1 has been reported to be the principal enzyme responsible for the catabolism of at-RA to the inactive polar metabolites, 4-hydroxy-RA (4-OH-RA) , 4oxo-RA, and 18-OH-RA [6-8].”
BackgroundReijntjes, S., Francis‐West, P. H., & Mankoo, B. S. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082783sr · Cited by 30
“, 1995) and retinoid deficiency targets the posterior rhombomeres (r4-8) whereby they never differentiate (Gale et al., 1999; White et al., 2000).”
BackgroundXenobiotic‐metabolizing Cytochromes P450 in Ontogeny: Evolving Perspective
Choudhary, D., Jansson, I., Sarfarazi, M., & Schenkman, J. B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033447 · Cited by 30
Okano, J., Sakai, Y., & Shiota, K. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21715 · Cited by 28
Rat, E., Billaut-Laden, I., Allorge, D., Lo‐Guidice, J., Tellier, M., Cauffiez, C., Jonckheere, N., SEUNINGEN, I. V., Lhermitte, M., Romano, A. G., et al. (2006) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20275 · Cited by 28
Oxytocin receptor behavioral effects and cell types in the bed nucleus of the stria terminalis
Luo, P. X., Zakharenkov, H. C., Torres, L. Y., Rios, R. A., Gegenhuber, B., Black, A. M., Xu, C. K., Minie, V. A., Tran, A. M., Tollkuhn, J., et al. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105203 · Cited by 27
Identification of influential proteins in the classical retinoic acid signaling pathway
Ghaffari, H., & Petzold, L. R. (2018) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-018-0088-7 · Cited by 27
Zuo, Q., Jin, J., Jin, K., Sun, C., Song, J., Zhang, Y., Chen, G., & Li, B. (2019) · Food & Function · doi:10.1039/c9fo01485c · Cited by 25
Etiology of Caudal Regression Syndrome
Semba, K. (2013) · Human Genetics & Embryology · doi:10.4172/2161-0436.1000107 · Cited by 25
Helvig, C. F., Taimi, M., Cameron, D. A., Jones, G., & Petkovich, M. P. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.08.005 · Cited by 24
Self-citationRegulation of germ line stem cell homeostasis.
Garcia, T. X., & Hofmann, M.-C. C. (2015) · PubMed · Cited by 23
Numayama‐Tsuruta, K., Arai, Y., Takahashi, M., Sasaki‐Hoshino, M., Funatsu, N., Nakamura, S., & Osumi, N. (2010) · BMC Developmental Biology · doi:10.1186/1471-213x-10-6 · Cited by 23
“Cyp26b1 is an RA-catabolizing enzyme that regulates RA signaling by promoting its degradation [20].”
BackgroundRühl, R., Plum, C., Elmazar, M. M., & Nau, H. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.1.82 · Cited by 23
Mutational screening of theCYP26A1gene in patients with caudal regression syndrome
Marco, P. D., Merello, E., Mascelli, S., Raso, A., Santamaria, A., Ottaviano, C., Calevo, M. G., Cama, A., & Capra, V. (2006) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20225 · Cited by 22
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Ocaya, P., Gidlöf, A. C., Olofsson, P. S., Törmä, H., & Sirsjö, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.138602 · Cited by 22
Qiu, L., Wei, S., Wang, Y.-S., Zhang, R., Ru, S., & Zhang, X. (2023) · Environment International · doi:10.1016/j.envint.2023.108217 · Cited by 22
Fritzsche, B., Vermot, J., Neumann, U., Schmidt, A., Schweigert�, F. J., Dollé, P., & Rühl, R. (2006) · Molecular Reproduction and Development · doi:10.1002/mrd.20526 · Cited by 21
“Besides ATRA, the CYP26A1 enzyme is able to oxidize ROL into 4-oxo-ROL (Lane et al., 1999) as well as 9-cis RA (White et al., 2000).”
BackgroundCYP26B1 as regulator of retinoic acid in vascular cells and atherosclerotic lesions
Elmabsout, A. A. (2012) · Cited by 37
Instructing Mouse Germ Cells to Adopt a Female Fate
Spiller, C. M., & Bowles, J. (2022) · Sexual Development · doi:10.1159/000523763 · Cited by 20
“Instructing Mouse Germ Cells to Adopt a Female Fate 347Sex Dev 2022;16:342–354 DOI: 10.1159/000523763 [White et al., 2000], these expression patterns suggested a system whereby endogenous levels of RA would build up once CYP26B1 was lost in the ovary and would be able to act directly on germ cells…”
BackgroundInfluentialFoti, R., Isoherranen, N., Zelter, A., Dickmann, L. J., Buttrick, B., Diaz, P., & Douguet, D. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232637 · Cited by 19
“1; UniProtKB Q9NR63), which had been isolated from human retinal cDNA (White et al., 2000).”
BackgroundHydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis
Chapman, J. S., Weiss, K. L., Curley, R. W., Highland, M. A., & Clagett‐Dame, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.09.001 · Cited by 19
Lin, C.-Y., Pan, T.-S., Ting, C., Liang, S., Huang, S., Liu, H., Ko, E. C., Wu, C.-W., Tang, J., & Chen, P. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/618032 · Cited by 18
Retinoic acid signaling and metabolism in heart failure
Parker, L. E., Papanicolaou, K. N., Zalesak‐Kravec, S., Weinberger, E. M., Kane, M. A., & Foster, D. B. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00871.2024 · Cited by 17
Vitamin E supplementation does not prevent ethanol-reduced hepatic retinoic acid levels in rats
Chung, J., Veeramachaneni, S., Liu, C., Mernitz, H., Russell, R. M., & Wang, X. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.09.008 · Cited by 17
“For example, the family of CYP26 enzymes was shown to metabolize RA [34-36].”
BackgroundNakajima, K., Umino, K.-I., Azuma, Y., Kosaka, S., Takano, K., Obara, T., & Sato, K. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0032-8 · Cited by 17
“It is also interesting that P450RAI-2, which is involved in the specific inactivation of all-trans-RA [38], was increased more than twofold.”
BackgroundRetinoic acid enhances germ cell differentiation of mouse skin-derived stem cells
Dyce, P. W., Tenn, N. A., & Kidder, G. M. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0390-3 · Cited by 16
“Conversely, in the male the activity of RA is stopped through the action of the retinoiddegrading enzyme cytochrome P450 26B1 (CYP26B1) [5].”
BackgroundCytochrome P450 26A1 Contributes to the Maintenance of Neuropathic Pain
Cao, D., Ma, L.-J., Jiang, B., Gu, Q., & Gao, Y. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01101-1 · Cited by 17
“In the adult, CYP26A1 is highly expressed in the liver, less in the brain and testis, and CYP26B1 is expressed mainly in brain tissue, but also at low levels in other tissues [20–22].”
BackgroundLu, C., Xu, M., Wang, Y., Qin, Y., Du, G., Wu, W., Han, X., Ji, C., Yang, Y., Gu, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053443 · Cited by 15
“RA plays an important role in the process of cell growth, differentiation and apoptosis, and is catabolized by a family of cytochrome P450 (CYP) enzymes, CYP26A1, CYP26B1 and CYP26C1 [10,11,12].”
BackgroundRicard, M. J., & Gudas, L. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.474254 · Cited by 15
“Cyp26b1 displays substrate specificity similar to that of Cyp26a1 (42); Cyp26b1 is expressed at thoracic but not brachial levels of the spinal cord (43).”
BackgroundFoti, R., Diaz, P., & Douguet, D. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1193734 · Cited by 15
Developmental expression of cytochrome CYP26B1 (P450RAI-2) in human cephalic tissues
Trofimova-Griffin, M. E., & Juchau, M. R. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00305-x · Cited by 15
Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromes
Bird, A. D., Croft, B., Harada, M., Tang, L., Zhao, L., Ming, Z., Bagheri‐Fam, S., Koopman, P. A., Wang, Z., Akita, K., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa100 · Cited by 14
Yao, X., Li, P., Liu, J., Yang, Y., Luo, Z., Jiang, H., He, W.-G., Luo, H., Deng, Y., & He, B. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00526-z · Cited by 13
Falker‐Gieske, C., Mott, A., Franzenburg, S., & Tetens, J. (2021) · BMC Genomics · doi:10.1186/s12864-021-07451-2 · Cited by 13
“CYP26B1 hydroxylates RA to 4-OH-RA, 4-oxo-RA, or 18-OH-RA [52].”
BackgroundGrace, C. S., Mikkola, H. K. A., Dou, D. R., Calvanese, V., Rönn, R. E., & Purton, L. E. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.287 · Cited by 12
Madanayake, T. W., Lindquist, I. E., Devitt, N. P., Mudge, J., & Rowland, A. M. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-833 · Cited by 12
Long-Distance Retinoid Signaling in the Zebra Finch Brain
Roeske, T. C., Scharff, C., Olson, C. R., Nshdejan, A., & Mello, C. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111722 · Cited by 13
Cloning and Functional Studies of a Splice Variant of CYP26B1 Expressed in Vascular Cells
Elmabsout, A. A., Kumawat, A. K., Méndez, P. S., Krivospitskaya, O., Sävenstrand, H., Olofsson, P. S., Eriksson, L. A., Strid, Å., Valen, G., Törmä, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036839 · Cited by 12
“It regulates intracellular levels of atRA and degrades it into inactive derivatives or polar metabolites such as 4-OH-RA, 4-oxo-RA, 5, 8-epoxy-RA and 18-OH-RA [8–11].”
BackgroundRegulation of murine embryonic patterning and morphogenesis by retinoic acid signaling
Pennimpede, T., Cameron, D. A., & Petkovich, M. P. (2006) · Advances in developmental biology · doi:10.1016/s1574-3349(06)16003-2 · Cited by 12
Self-citationZhang, A. J., Liu, S., Zhu, J., Gu, Z. M., Zhou, Z., Zhang, G. F., & Lu, K. (2016) · AquaDocs (United Nations Educational, Scientific and Cultural Organization) · doi:10.22092/ijfs.2018.114620 · Cited by 11
Self-citationMéndez, P. S., Elmabsout, A. A., Sävenstrand, H., Awadalla, M. K. A., Strid, Å., Sirsjö, A., & Eriksson, L. A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300264u · Cited by 10
Rhie, A., Son, H., Kwak, S. J., Lee, S., Kim, D. Y., Lew, B., Sim, W., Seo, J., Kwon, O., Kim, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222533 · Cited by 10
“CYP26A1 and CYP26B1 are expressed and are RA-inducible in both reconstructed and in vivo human epidermis [39, 40], but CYP26B1 was suggested to be more effective under physiological conditions [41], CYP26B1 is able to inactivate both all-trans -RA and 9-cis -RA [42].”
Issa, R. S., Kaehler, M., Pommert, N. S., Cascorbi, I., & Waetzig, V. (2024) · Anticancer Research · doi:10.21873/anticanres.17249 · Cited by 9
The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma
Wang, R., Liu, Z., Chen, W., Yang, Y., & Peng, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.066 · Cited by 9
Wu, S.-J., Chen, Y., Shieh, T., Chen, C., Wang, Y., Lee, K.-T. D., Lin, Y.-M., Chien, P., & Chen, P. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/160185 · Cited by 10
Moramarco, F., & McCaffery, P. J. A. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0177 · Cited by 8
Petkova-Kirova, P. S., Baas, S., Wagenpfeil, G., Hartz, P., Unger, M. M., & Bernhardt, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1244516 · Cited by 8
Vitamin A: Nutritional Aspects of Retinoids and Carotenoids
Ross, A. C., & Harrison, E. H. (2007) · CRC Press eBooks · doi:10.1201/9781420005806.ch1 · Cited by 8
Germ Cell Sex Determination: Piecing Together a Complex Puzzle
Wawersik, M. J. (2006) · Cell Cycle · doi:10.4161/cc.5.13.2905 · Cited by 9
Isoherranen, N., & Wen, Y. W. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.09.001 · Cited by 7
From Carotenoids and Vitamin A to Retinoids
Blomhoff, R., & Blomhoff, H. K. (2007) · Basic and clinical dermatology · doi:10.3109/9781420021189.001 · Cited by 7
Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1
Awadalla, M. K. A., Alshammari, T. M., Eriksson, L. A., & Méndez, P. S. (2016) · Molecules · doi:10.3390/molecules21030351 · Cited by 8
Varshosaz, P., O'Connor, C., & Moise, A. R. (2024) · FEBS Letters · doi:10.1002/1873-3468.15038 · Cited by 6
Organizer Activities Mediated by Retinoic Acid Signaling
Chen, Y., Hollemann, T., & Pieler, T. (2004) · Springer eBooks · doi:10.1007/978-3-662-10416-3_11 · Cited by 6
Topletz, A. R. (2013) · ResearchWorks at the University of Washington (University of Washington) · Cited by 6
Khosasih, V., Liu, K.-M., Huang, C., Liou, L.-B., Hsieh, M., Lee, C., Tsai, C., Kuo, S., Hwa, S., Yu, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033021 · Cited by 5
“CYP26B1 plays an important role in the vitamin A metabolism pathway by catabolizing excess retinoic acid into its inactive polar forms [28].”
BackgroundLopez-Real, R. E., Budge, J., Marder, T. B., WHITING, A., Hunt, P., & Przyborski, S. A. (2013) · Journal of Anatomy · doi:10.1111/joa.12147 · Cited by 5
“Oxidation of retinoids by the CYP26 enzymes is generally thought to result in their inactivation (White et al. 1996, 2000; Fujii et al. 1997).”
Ross, A. C., Hodges, J. K., Wei, C., & Li, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-805378-2.00016-4 · Cited by 5
Buttrick, B. (2013) · ResearchWorks at the University of Washington (University of Washington) · Cited by 5
Kasimanickam, V. R., & Kasimanickam, R. K. (2012) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2012.02125.x · Cited by 4
Metadata
- Authors
- White, J. A., Ramshaw, H., Taimi, M., Stangle, W., Zhang, A., Everingham, S., Creighton, S., Tam, S.-P., Jones, G., & Petkovich, M.
- Affiliations
- Queen's University (CA)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-05-23
- Volume
- 97
- Issue
- 12
- Pages
- 6403-6408
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18615
- OpenAlex
- W2085511966
- Cited by
- 248
- References
- 30
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 1 · 2016: 10 · 2015: 11 · 2014: 5 · 2013: 15 · 2012: 16
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- cytochrome P450, cerebellum, passive optical networks, human brain, gene cloning, enzyme substrate specificity, 4-oxo-retinoic acid, tissue-specific gene expression
- MeSH terms
- Retinoic Acid 4-Hydroxylase, Amino Acid Sequence, Base Sequence, Cells, Cultured, Cerebellum, Cloning, Molecular, Cytochrome P-450 Enzyme System, Humans, Mixed Function Oxygenases, Molecular Sequence Data, Substrate Specificity, Tretinoin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.